Local Anaesthetic · Class IB Antiarrhythmic

Lidocaine HCl

Dual-indication sterile anaesthetic — from regional nerve blocks to emergency cardiac arrhythmia management — in precise prefilled syringe format.

PFS 1% (10 mg/mL) & 2% (20 mg/mL) GMP Certified Made in India
Pharmacology

Mechanism of Action

Lidocaine blocks fast voltage-gated sodium channels in neuronal membranes, preventing depolarisation and action potential propagation. In cardiac tissue, it selectively suppresses automaticity in the His-Purkinje system with minimal effect on normal conduction, making it effective for ventricular arrhythmias.

Clinical Evidence

Key Clinical Data Points

<5 min
Onset of local anaesthetic action
depending on injection site
1–3 hrs
Duration of nerve block
without epinephrine
65%
Plasma protein bound
to α1-acid glycoprotein
90 min
Elimination half-life
hepatic metabolism (CYP1A2)
Therapeutic Applications

Approved Indications

Regional and epidural anaesthesia
Peripheral nerve blocks
Cardiac ventricular arrhythmias
Procedural pain management in ICU
Wound infiltration anaesthesia
Manufacturing Advantage

Why Manufacture Lidocaine with Addams

Available in 1% and 2% concentrations in separate SKUs
Epinephrine-free formulations for cardiac safety
pH adjusted to 6.0–7.0 for tissue compatibility
Graduated markings on syringe barrel for dose precision
Request Manufacturing Quote
Get pricing, MOQ, and feasibility for Lidocaine HCl within 24 hours.
Get Quote → Start Discussion
Ready to Manufacture Lidocaine?
Our team responds within 24 hours with a full feasibility and pricing overview.
Get QuoteSee Full Portfolio